Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_assertion type Assertion NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_head.
- NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_assertion description "[With a single exception, all primary EOC that overexpressed TF demonstrated high levels of CD46, CD55 and CD59 and regardless of their histology or resistance to chemotherapy, were highly sensitive to IDCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_provenance.
- NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_assertion evidence source_evidence_literature NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_provenance.
- NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_assertion SIO_000772 21725665 NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_provenance.
- NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_assertion wasDerivedFrom befree-20140225 NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_provenance.
- NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_assertion wasGeneratedBy ECO_0000203 NP567329.RAWoeJnHiMktmA2Fvo8lrNeky9fWn8jYnYymlwuNU-bOs130_provenance.